Pharma
|
PharmaConsult Global
Global Health Training C
Training and guidance is vital for pharmaceutical firms especially those who are hoping to trade overseas
onsultants are vital to healthcare companies looking to operate globally, especially in the areas
of distribution, training and product development. PharmaConsult is an international consultancy and bespoke training provider. Working with clients across the full
spectrum of healthcare services in Europe, USA, Middle East and Asia, from blue-chip multinational Pharmaceutical companies (GSK & Novartis), biotech start-ups (Julphar UEA) to generic companies (Activas), Regulatory Authorities (SFDA), and Local Ministers of health (UAE). Pharma Consult offers
global-opportunity.co.uk
a consultancy service to companies operating in all pharmaceutical markets, helping to develop their portfolio of products and to achieve high performance and best cost effective practice from their operating systems. Services range from advice on
product registration, specialist product development, regulatory compliance auditing, quality management systems
for medicines supply chains and pharmacovigilance. On the international front this year the
company will provide national conference briefings in Delhi, Istanbul, Riyadh, Dubai, Brazil and The Netherlands. PharmaConsult claims it differs from
other companies in that it provides a personalised consultancy service tailor- made to needs and appropriate to the markets in which clients operate. This can be compliance audit services to survive a regulatory GXP inspection, or a turnkey solution to commissioning a new factory or laboratory site. For companies looking to operate
Issue 01 | Global Opportunity Healthcare 2015 87
PharmaConsult Global
|
IMAGE:
WWW.SHUTTERSTOCK.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128